Automated live-cell imaging platform for advanced Alzheimer’s research at NSU
Official title: Automated Live-Cell Imaging Platform with Convertible Fluorescence Microscope
Funded at Nova Southeastern University · NIH-11364772 · Data updated 2026-11-12
A new high-end microscope will be installed at Nova Southeastern University to help researchers study Alzheimer’s disease and related conditions using live-cell and tissue imaging.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nova Southeastern University NIH-funded |
| Lab location | 1 site (Fort Lauderdale-Davie, UNITED STATES) |
| Project start | September 4, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $173,089 |
| NIH project number | 1S10DE037202-01 |
| Project ID | NIH-11364772 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable (this grant is a core facility instrument acquisition; patient participation would occur only in related future studies that use the facility).
✕Less likely to help
This grant itself does not enroll participants; patient benefits would arise from future studies using the instrument.
What this research studies
This grant funds the Discover Echo Revolution microscope for NSU’s Imaging Core Facility, enabling high-resolution fluorescence and brightfield imaging with live-cell incubation. The instrument’s versatility supports experiments on live and fixed cells, tissue sections, organoids, and multiwell assays, and is designed for broad use across neuroscience, cancer biology, and other biomedical fields. By expanding core capabilities, NSU researchers and external collaborators can pursue more detailed visual analyses of Alzheimer’s disease models and related biology. The project emphasizes shared access, cross-institution collaboration, and enhanced workflows to accelerate discovery in resource-limited settings.
Why it matters
Potential benefit: The new imaging platform could accelerate understanding of Alzheimer’s disease mechanisms and aid in developing therapies by providing clearer, real-time visuals of cellular processes.
How similar studies have gone: Core facility instrument upgrades have historically enabled faster data generation and collaboration, with subsequent studies translating into patient-focused work.
Where this research is happening
-
Nova Southeastern University
Fort Lauderdale-Davie, United States Active
Researchers
- Principal investigator: Krueger, Robin L. — Nova Southeastern University
- Study coordinator: Krueger, Robin L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.